Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
Article
[키워드] analysed
Analysis
antibodies
antibody
Antibody Response
antibody-based therapy
B cell
B.1.1.7
B.1.351
B.1.617.2
Beta
BNT162b2 mRNA vaccine
breadth
Cell
convalescent
COVID-19
Delta
Effectiveness
escaped
FIVE
Gamma
hybrid
Immunity
impacted
IMPROVE
individual
Infection
Infectious diseases
memory B cell
monoclonal
monoclonal antibody
neutralization
neutralized
Neutralizing antibodies
produced
response to vaccination
SARS-CoV-2
SARS-CoV-2 variant
SARS-CoV-2 variants
SARS-CoV-2 virus
seropositive
significantly higher
single-cell level
the antibody
the spike protein
vaccination
Vaccine
Vaccines
variant
variants
virus
Wuhan, China
[DOI] 10.1038/s41586-021-04117-7 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41586-021-04117-7 PMC 바로가기 [Article Type] Article